UniProt ID | UBP19_MOUSE | |
---|---|---|
UniProt AC | Q3UJD6 | |
Protein Name | Ubiquitin carboxyl-terminal hydrolase 19 | |
Gene Name | Usp19 | |
Organism | Mus musculus (Mouse). | |
Sequence Length | 1360 | |
Subcellular Localization |
Endoplasmic reticulum membrane Single-pass membrane protein. |
|
Protein Description | Deubiquitinating enzyme that regulates the degradation of various proteins. Deubiquitinates and prevents proteasomal degradation of RNF123 which in turn stimulates CDKN1B ubiquitin-dependent degradation thereby playing a role in cell proliferation. Involved in decreased protein synthesis in atrophying skeletal muscle. Modulates transcription of major myofibrillar proteins. Also involved in turnover of endoplasmic-reticulum-associated degradation (ERAD) substrates (By similarity). Regulates the stability of BIRC2/c-IAP1 and BIRC3/c-IAP2 by preventing thier ubiquitination. Required for cells to mount an appropriate response to hypoxia and rescues HIF1A from degradation in a non-catalytic manner. Exhibits a preference towards 'Lys-63'-linked ubiquitin chains (By similarity). Plays an important role in 17 beta-estradiol (E2)-inhibited myogenesis. Decreases the levels of ubiquitinated proteins during skeletal muscle formation and acts to repress myogenesis.. | |
Protein Sequence | MSAGASATGPRRGPPGLEEATSKKKQKDRANLESKDGDARRVSLPRKEPTKDELLLDWRQSADEVIVKLRVGTGPVRLEDVDAAFTDTDCVVRLPDGRQWGGVFFAEIQSSCTKVQARKGGLLQLVLPKKVPLLTWPSLLKPLGTQELVPGLQCQENGQELSPIALEPGSEPRRAKQEARNQKRAQGRGEVGSGAGPGTQAGPSAKRAVHLRRGPEGEGSMDGPGPQGDAPSFLSDSATQVEAEEKLCAPPMNTQTSLLSSEKSLALLTVEKTVSPRNDPVAPVMVQDRDPEPEQEDQVKEEMALGADPTALVEEPESMVNLAFVKNDSYEKGPDSVVVHVYVKEIRRDSSRVLFREQDFTLIFQTRDGNFLRLHPGCGPHTIFRWQVKLRNLIEPEQCTFCFTASRIDICLRKRQSQRWGGLEAPATRGAVGGAKVAVPTGPTPLDSTPPGGGPHPLTGQEEARAVEKEKPKARSEDSGLDGVVARTPLEHVAPKPDPHLASPKPTCMVPPMPHSPVSGDSVEEDEEEEKKVCLPGFTGLVNLGNTCFMNSVIQSLSNTRELRDFFHDRSFEAEINYNNPLGTGGRLAIGFAVLLRALWKGTHQAFQPSKLKAIVASKASQFTGYAQHDAQEFMAFLLDGLHEDLNRIQNKPYTETVDSDGRPDEVVAEEAWQRHKMRNDSFIVDLFQGQYKSKLVCPVCAKVSITFDPFLYLPVPLPQKQKVLPIFYFAREPHSKPIKFLVSVSKENSSASEVLDSLSQSVHVKPENLRLAEVIKNRFHRVFLPSHSLDAVSPTDVLLCFELLSPELAKERVVVLEVQQRPQVPSIPISKCAACQRKQQSEEEKLKRCTRCYRVGYCNQFCQKTHWPDHKGLCRPENIGYPFLVSVPASRLTYARLAQLLEGYARYSVSVFQPPFQPGRMALESQSPGCTTLLSTSSLEAGDSEREPIQPSELQLVTPVAEGDTGAHRVWPPADRGPVPSTSGLSSEMLASGPIEGCPLLAGERVSRPEAAVPGYQHSSESVNTHTPQFFIYKIDASNREQRLEDKGETPLELGDDCSLALVWRNNERLQEFVLVASKELECAEDPGSAGEAARAGHFTLDQCLNLFTRPEVLAPEEAWYCPQCKQHREASKQLLLWRLPNVLIVQLKRFSFRSFIWRDKINDLVEFPVRNLDLSKFCIGQKEEQLPSYDLYAVINHYGGMIGGHYTACARLPNDRSSQRSDVGWRLFDDSTVTTVDESQVVTRYAYVLFYRRRNSPVERPPRASHSEHHPDLGPAAEAAASQASRIWQELEAEEEMVPEGPGPLGPWGPQDWVGPPPRGPTTPDEGCLRYFVLGTVAALVALVLNVFYPLVSQSRWR | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
34 | Phosphorylation | KDRANLESKDGDARR HHHHCCCCCCCCCCC | 38.93 | 22705319 | |
43 | Phosphorylation | DGDARRVSLPRKEPT CCCCCCCCCCCCCCC | 30.74 | 24719451 | |
162 | Phosphorylation | QENGQELSPIALEPG CCCCEECCCEECCCC | 17.32 | 26745281 | |
220 | Phosphorylation | RGPEGEGSMDGPGPQ CCCCCCCCCCCCCCC | 14.92 | 25521595 | |
232 | Phosphorylation | GPQGDAPSFLSDSAT CCCCCCCHHHCCCCC | 40.31 | 27742792 | |
264 | Phosphorylation | SLLSSEKSLALLTVE HHHCCHHHEEEEEEE | 18.15 | 29899451 | |
441 | Phosphorylation | GAKVAVPTGPTPLDS CCEEEECCCCCCCCC | 49.55 | 25293948 | |
444 | Phosphorylation | VAVPTGPTPLDSTPP EEECCCCCCCCCCCC | 37.52 | 25293948 | |
448 | Phosphorylation | TGPTPLDSTPPGGGP CCCCCCCCCCCCCCC | 50.96 | 26745281 | |
449 | Phosphorylation | GPTPLDSTPPGGGPH CCCCCCCCCCCCCCC | 32.92 | 26239621 | |
459 | Phosphorylation | GGGPHPLTGQEEARA CCCCCCCCCHHHHHH | 41.07 | 25293948 | |
476 | Phosphorylation | KEKPKARSEDSGLDG HHCCCCCCCCCCCCC | 51.09 | - | |
488 | Phosphorylation | LDGVVARTPLEHVAP CCCEEECCCHHHCCC | 23.61 | 21454597 | |
503 | Phosphorylation | KPDPHLASPKPTCMV CCCCCCCCCCCCEEC | 39.55 | 26060331 | |
516 | Phosphorylation | MVPPMPHSPVSGDSV ECCCCCCCCCCCCCC | 22.56 | 30352176 | |
519 | Phosphorylation | PMPHSPVSGDSVEED CCCCCCCCCCCCCCC | 40.02 | 26643407 | |
522 | Phosphorylation | HSPVSGDSVEEDEEE CCCCCCCCCCCCHHH | 34.65 | 26643407 | |
652 | Ubiquitination | DLNRIQNKPYTETVD HHHHHHCCCCCCEEC | 24.03 | 22790023 | |
693 | Ubiquitination | DLFQGQYKSKLVCPV HHHCCCCCCCEECCC | 32.97 | 22790023 | |
721 | Ubiquitination | LPVPLPQKQKVLPIF CCCCCCCCCCEEEEE | 50.58 | - | |
777 | Ubiquitination | LRLAEVIKNRFHRVF CHHHHHHHHCCCEEE | 47.44 | 22790023 | |
1153 | Phosphorylation | IVQLKRFSFRSFIWR EEEECCCCCHHHHHH | 24.63 | 24719451 | |
1162 | Ubiquitination | RSFIWRDKINDLVEF HHHHHHHHCCHHEEC | 34.53 | 22790023 | |
1178 | Ubiquitination | VRNLDLSKFCIGQKE CCCCCHHHHHCCCCC | 52.10 | 22790023 | |
1191 | Phosphorylation | KEEQLPSYDLYAVIN CCCCCCCCCHHEEHH | 14.18 | 28494245 | |
1194 | Phosphorylation | QLPSYDLYAVINHYG CCCCCCHHEEHHHCC | 8.91 | 28494245 | |
1200 | Phosphorylation | LYAVINHYGGMIGGH HHEEHHHCCCCCCCE | 15.75 | 28494245 | |
1258 | Phosphorylation | LFYRRRNSPVERPPR EEECCCCCCCCCCCC | 28.63 | 29899451 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of UBP19_MOUSE !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of UBP19_MOUSE !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of UBP19_MOUSE !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
RN123_MOUSE | Rnf123 | physical | 19015242 | |
MARH6_HUMAN | MARCH6 | physical | 25088257 | |
UBC_HUMAN | UBC | physical | 25088257 |
Kegg Drug | ||||||
---|---|---|---|---|---|---|
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...